Skip to content

13F-HR filed by SABBY MANAGEMENT, LLC

SABBY MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 39 holding rows worth $86,449,717.

Accession
0001104659-25-111938
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 39 entries on the cover page, a total value of $86,449,717 stated on the cover page (in dollars after the unit check, H1), rows summing to $86,449,717 with VALUE read as dollars as filed, 13F file number 028-15245. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerHal Mintz

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR464287905CALL834$20,179,464dollars as filedcall
SPDR S&P 500 ETF TR78462F953PUT259$17,254,062dollars as filedput
ISHARES TR464287955PUT704$17,033,984dollars as filedput
BIG TREE CLOUD HLDGS LTDG1263B108SHS7,720,762$8,029,592dollars as filed
STATE STR SPDR S&P 500 ETF T78462F903CALL118$7,860,924dollars as filedcall
EOS ENERGY ENTERPRISES INC29415C951PUT3,503$3,989,917dollars as filedput
EMPERY DIGITAL INC92864V608COM NEW225,058$1,692,436dollars as filed
POP CULTURE GROUP CO LTDG71700119SHS NEW1,227,666$1,092,254dollars as filed
EVE HLDG INC29970N104COM232,458$885,665dollars as filed
CAN FITE BIOFARMA LTD13471N300SPONSORED ADR1,406,050$870,626dollars as filed
LYRA THERAPEUTICS INC55234L204COM NEW127,624$832,874dollars as filed
OCEANPAL INCY6430L301COM NEW668,969$822,832dollars as filed
LM FDG AMER INC502074503COM NEW638,250$727,605dollars as filed
BIOAFFINITY TECHNOLOGIES INC09076W307COM NEW242,757$718,561dollars as filed
U POWER LTDG9520U116USD CL A ORD SHS240,260$485,325dollars as filed
INMED PHARMACEUTICALS INC457637700COM NEW219,998$481,796dollars as filed
EPICQUEST EDUCATN GRP INTL LG3104J100COM900,765$400,840dollars as filed
SENESTECH INC81720R604COM NEW71,283$312,932dollars as filed
GEOVAX LABS INC373678606COM SHS661,376$312,897dollars as filed
ZEVRA THERAPEUTICS488445956COM327$310,977dollars as filedput
REVELATION BIOSCIENCES INC76135L705COM NEW 2025207,051$294,012dollars as filed
GEVO INC374396956COM PAR1,403$274,988dollars as filedput
VISION MARINE TECHNOLOGIES I92840Q301COM186,536$253,689dollars as filed
CORE SCIENTIFIC INC NEW21874A956PUT130$233,220dollars as filedput
WORK MED TECHNOLOGY GROUP LTG9767H109SHS CL A2,724,004$204,028dollars as filed
CEMTREX INC15130G873COM24,987$141,426dollars as filed
BRIACELL THERAPEUTICS CORP107930117*W EXP 99/99/999374,488$125,453dollars as filed
NUWELLIS INC67113Y702COM NEW35,894$120,245dollars as filed
SOLIGENIX INC834223604COM NEW81,000$93,960dollars as filed
AIM IMMUNOTECH INC00901B303CMN28,855$79,063dollars as filed
ORAGENICS INC684023609COM58,953$77,228dollars as filed
TOKEN CAT LTD89856T401SPONSORED ADS3,983$55,251dollars as filed
BLUEJAY DIAGNOSTICS INC095633509COM NEW29,628$45,035dollars as filed
RUBICO INCY1250N107ORD SHS20,835$44,170dollars as filed
ACURX PHARMACEUTICALS INC00510M203COM NEW8,705$37,344dollars as filed
SOLAI LIMITED055474959SPON ADR134$36,180dollars as filedput
CORE SCIENTIFIC INC NEW21874A106COM1,040$18,658dollars as filed
SOLAI LIMITED055474209SPON ADR3,865$10,436dollars as filed
REVIVA PHARMACEUTCLS HLDGS INC76152G950COM265$9,768dollars as filedput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-111938this filing2025-11-14acceptance time not in the bulk data set